Jump to content

Prenatal Antibody Titers


RRay

Heterozygous or Homozygous cell for Prenatal Antibody Titers.  

22 members have voted

  1. 1. Which cell type and methodology do you use for Prenatal Antibody Titration?

    • Heterozygous - Gel
    • Homozygous - Gel
    • Heterozygous - Tube
    • Homozygous - Tube


Recommended Posts

Well, the first thing to say is that red cells CANNOT be either homozygous or heterozygous (or, come to that, hemizygous).  These terms apply ONLY to genes, and red cells do not contain a nucleus.  The antigens can only be described as, at best, "homozygous", "heterozygous" or "hemizygous" expression, or, alternatively, "double" or "single dose" expression.

Then, it HAS to be accepted that, unless the maternal antibody is an autoantibody, it must be an alloantibody (or, possibly, an isoantibody), which means that to mimic the state of the foetal red cells, the red cells used to titrate the antibody MUST have a "single dose" expression.  However, that in itself presupposes that the foetal red cell antigens are all expressed at the same time, which we know is untrue (just look at the A, B and H antigens as an obvious example, but also the Kell antigens that are expressed much earlier than are the Rh antigens) or are ONLY expressed on foetal red cells, as opposed to other tissues (such as on the placental cells, which have, in some cases, been proved to adsorb the maternal antibodies).

Then, there is the fact that not all antibodies can be detected by all techniques.  This is why Reference Laboratories SHOULD have more than one technology available (and their workers should be provably competent in these techniques.  However, even then, not all techniques can predict the severity or otherwise of HDFN.  For example, antibodies within the Indian Blood Group System always show that they can cause severe HDFN by certain techniques, such as MMA, but they don't!  There is also the fact that the immunoglobulins may be IgM, IgA, IgG1, IgG2, IgG3 and IgG4 (to mention just a few), and I have yet to come across, or read about, an IgG4 immunoglobulin causing HDFN.

So, my answer is that there is a HUGE amount of knowledge known about the various antibody specificities, their titres, the expression of their cognate antigen, etc, etc, that there CANNOT be a single answer to your excellent question, but that the best thing that can be done is to read around the subject - and read around the subject from every source available - not just from a single country.

OKAY THEN, RIP ME APART!!!!!!!!!!!

Link to comment
Share on other sites

Well stated @Malcolm Needs!

Semantics aside, I do see the reasoning behind either antigen configuration. Definitely different purposes though.

I did reach out to CAP to ask which they are using for their Anti-D titer PT sample.  Seems that if we are tasked with being in range with peers or their "answer key" I'd like to know what they are using as routine.  They have no documentation of what guidelines they routinely use for titer cell selection.  Hmm.. 

Link to comment
Share on other sites

10 minutes ago, RRay said:

Well stated @Malcolm Needs!

Semantics aside, I do see the reasoning behind either antigen configuration. Definitely different purposes though.

I did reach out to CAP to ask which they are using for their Anti-D titer PT sample.  Seems that if we are tasked with being in range with peers or their "answer key" I'd like to know what they are using as routine.  They have no documentation of what guidelines they routinely use for titer cell selection.  Hmm.. 

The UK has (I was one of the co-authors).

Guideline for blood grouping and red cell antibody testing in pregnancy.  White, J, Qureshi, H, Massey, E, Needs, M, Byrne, G, Daniels, G, Allard S, British Committee for Standards in Haematology.  Transfusion Medicine, 2016, 26, 246–263.  doi: 10.1111/tme.12299.

Link to comment
Share on other sites

I've been thinking about this question and I don't remember if our SOP specified what type of cell to use (I've slept a couple of times since last performing a titer).  What I do remember was that we wanted to use the same type with every repeat during the pregnancy.  In other words if the initial titer was done using an R1R1 cell for anti-D then every subsequent titer was performed with an R1R1 cell.  At the time, the change in titer was considered the most important finding.  Also, again I'm trying to awaken long dormant memories, we used a tube/saline or tube/albumin technique ( can't remember which) because that was how the original studies were done for anti-D and how the values utilized by the OB docs were derived.  I know this is ancient history for many of you but thought I would throw it out there.  

I seem to remember that titers were going out of vogue  about the time I retired and there were much more accurate methods of determining the effect on the fetus from maternal antibodies coming into use.

:coffeecup:

 

Link to comment
Share on other sites

  • 2 weeks later...

How do you titer if the mom has more than one antibody?  Our policy is to titer each individually if possible.  However, I know other facilities find a cell that is positive for all of the antibodies so as to give the "overall" titer if you will.  

Link to comment
Share on other sites

  • 3 weeks later...

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.
  • Advertisement

×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.